Literature DB >> 23803270

A pilot randomized trial evaluating low-level laser therapy as an alternative treatment to manual lymphatic drainage for breast cancer-related lymphedema.

Sheila H Ridner1, Ellen Poage-Hooper, Collin Kanar, Jennifer K Doersam, Stewart M Bond, Mary S Dietrich.   

Abstract

PURPOSE/
OBJECTIVES: To examine the impact of advanced practice nurse (APN)-administered low-level laser therapy (LLLT) as both a stand-alone and complementary treatment for arm volume, symptoms, and quality of life (QOL) in women with breast cancer-related lymphedema.
DESIGN: A three-group, pilot, randomized clinical trial.
SETTING: A private rehabilitation practice in the southeastern United States. SAMPLE: 46 breast cancer survivors with treatment-related lymphedema.
METHODS: Patients were screened for eligibility and then randomized to either manual lymphatic drainage (MLD) for 40 minutes, LLLT for 20 minutes, or 20 minutes of MLD followed by 20 minutes of LLLT. Compression bandaging was applied after each treatment. Data were collected pretreatment, daily, weekly, and at the end of treatment. MAIN RESEARCH VARIABLES: Independent variables consisted of three types of APN-administered lymphedema treatment. Outcome variables included limb volume, extracellular fluid, psychological and physical symptoms, and QOL.
FINDINGS: No statistically significant between-group differences were found in volume reduction; however, all groups had clinically and statistically significant reduction in volume. No group differences were noted in psychological and physical symptoms or QOL; however, treatment-related improvements were noted in symptom burden within all groups. Skin improvement was noted in each group that received LLLT.
CONCLUSIONS: LLLT with bandaging may offer a time-saving therapeutic option to conventional MLD. Alternatively, compression bandaging alone could account for the demonstrated volume reduction. IMPLICATIONS FOR NURSING: APNs can effectively treat lymphedema. APNs in private healthcare practices can serve as valuable research collaborators. KNOWLEDGE TRANSLATION: Lasers may provide effective, less burdensome treatment for lymphedema. APNs with lymphedema certification can effectively treat this patient population with the use of LLLT. In addition, bioelectrical impedance and tape measurements can be used to assess lymphedema.

Entities:  

Mesh:

Year:  2013        PMID: 23803270      PMCID: PMC3887507          DOI: 10.1188/13.ONF.383-393

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  27 in total

1.  Low-level laser treatment can reduce edema in second degree ankle sprains.

Authors:  Apostolos Stergioulas
Journal:  J Clin Laser Med Surg       Date:  2004-04

2.  Radical axillary dissection in the staging and treatment of breast cancer.

Authors:  A B Ball; R Waters; S Fish; J M Thomas
Journal:  Ann R Coll Surg Engl       Date:  1992-03       Impact factor: 1.891

Review 3.  Incidence of breast carcinoma-related lymphedema.

Authors:  J A Petrek; M C Heelan
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

Review 4.  Chronic arm edema following breast cancer treatment.

Authors:  A W Stanton; J R Levick; P S Mortimer
Journal:  Kidney Int Suppl       Date:  1997-06       Impact factor: 10.545

Review 5.  Lymphedema.

Authors:  S G Rockson
Journal:  Am J Med       Date:  2001-03       Impact factor: 4.965

6.  Macrophage responsiveness to light therapy.

Authors:  S Young; P Bolton; M Dyson; W Harvey; C Diamantopoulos
Journal:  Lasers Surg Med       Date:  1989       Impact factor: 4.025

7.  Edema volume, not timing, is the key to success in lymphedema treatment.

Authors:  S M Ramos; L S O'Donnell; G Knight
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

8.  Evaluation of combined fractional radiofrequency and fractional laser treatment for acne scars in Asians.

Authors:  Chi K Yeung; Nicola P Y Chan; Samantha Y N Shek; Henry H L Chan
Journal:  Lasers Surg Med       Date:  2012-08-16       Impact factor: 4.025

9.  Risk of lymphoedema following the treatment of breast cancer.

Authors:  M W Kissin; G Querci della Rovere; D Easton; G Westbury
Journal:  Br J Surg       Date:  1986-07       Impact factor: 6.939

10.  Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.

Authors:  Lee Gravatt Wilke; Linda M McCall; Katherine E Posther; Pat W Whitworth; Douglas S Reintgen; A Marilyn Leitch; Sheryl G A Gabram; Anthony Lucci; Charles E Cox; Kelly K Hunt; James E Herndon; Armando E Giuliano
Journal:  Ann Surg Oncol       Date:  2006-03-02       Impact factor: 5.344

View more
  15 in total

Review 1.  Rehabilitation interventions for the management of breast cancer-related lymphedema: developing a patient-centered, evidence-based plan of care throughout survivorship.

Authors:  Kathryn Ryans; Marisa Perdomo; Claire C Davies; Kimberly Levenhagen; Laura Gilchrist
Journal:  J Cancer Surviv       Date:  2021-01-22       Impact factor: 4.442

2.  Development and validation of the Lymphedema Symptom and Intensity Survey-Arm.

Authors:  Sheila H Ridner; Mary S Dietrich
Journal:  Support Care Cancer       Date:  2015-03-10       Impact factor: 3.603

Review 3.  Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.

Authors:  Heather Greenlee; Lynda G Balneaves; Linda E Carlson; Misha Cohen; Gary Deng; Dawn Hershman; Matthew Mumber; Jane Perlmutter; Dugald Seely; Ananda Sen; Suzanna M Zick; Debu Tripathy
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

Review 4.  Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis.

Authors:  Betty Smoot; Laura Chiavola-Larson; Jeannette Lee; Hidelisa Manibusan; Diane D Allen
Journal:  J Cancer Surviv       Date:  2014-11-29       Impact factor: 4.442

Review 5.  The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature.

Authors:  Jolien Robijns; Sandrine Censabella; Paul Bulens; Annelies Maes; Jeroen Mebis
Journal:  Lasers Med Sci       Date:  2016-08-19       Impact factor: 3.161

Review 6.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

Review 7.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

8.  Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.

Authors:  Pamela L Ostby; Jane M Armer; Paul S Dale; Margaret J Van Loo; Cassie L Wilbanks; Bob R Stewart
Journal:  J Pers Med       Date:  2014-08-18

9.  Manual lymphatic drainage and quality of life in patients with lymphoedema and mixed oedema: a systematic review of randomised controlled trials.

Authors:  Martin Müller; Karsten Klingberg; Maria M Wertli; Helena Carreira
Journal:  Qual Life Res       Date:  2018-02-05       Impact factor: 4.147

Review 10.  Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review.

Authors:  G David Baxter; Lizhou Liu; Simone Petrich; Angela Spontelli Gisselman; Cathy Chapple; Juanita J Anders; Steve Tumilty
Journal:  BMC Cancer       Date:  2017-12-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.